The highest percentage of ALS patients carrying the intermediate repeat expansion has been reported from Brazil, where 6.3% (29/459 patients) of ALS patients were tested positive for ATXN2 intermediate alleles [48]. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.